Index,Name,MRN,DOB,Age,Weight,Height,Gender,Race,Performance Status,Treatment Site,T,N,M,Indication/Risk Group NCCN,Primary Site,Metastasis,No. of Nodes,Staging System,Histology/Pathology,Margin,PSA,Gleason,Recurrence,Size in Volume,Size in Dimension,Location,Clinical Risk Factors,Treatment Intent,Retreat,Prior RT,Surgery,Chemtherapy,Hormone,Immunotherapy,Androgen Deprivation (ADT)
1,,13937852,11/14/46,70,80 kg,180 cm,M,,0,Prostate,2a ,0,0,Intermediate,Prostate,0,0,Clinical,Carcinoma,,8.3,4+3=7,No,29,3.8 x 3.2 x 4.6,,,Curative,No,No,No,,,,Lupron 6 mo
2,,14622383,3/31/61,60,75,177cm,M,,1,Prostate,3b,0,0,Very High,Prostate,0,0,Clinical,Carcinoma,,62.9,4+4,No,31,3.8 x 3.6 x 4.3,,,Curative,None,None,None,,,,Lupron 18 mo
3,,20210910,,55,70,190,,,0,Prostate Bed,3a,0,0,,Prostate,,,Pathological,Carcinoma,,0.23,4+4,Yes,,,,,Salvage,None,None,Yes,,,,Lupron 6 months
4,,20210911,,67,85,170,,,1,Prostate,1c,0,0,Intermediate,Prostate,0,0,Clinical,Carcinoma,,9.9,3+4=7,No,55,4.9 x 4.4 x 4.6,,,Curative,None,None,None,,,,None
5,,20210913,,81,65,164,,,0,Prostate Bed,2,0,0,Very High,Prostate,,,Pathological,Carcinoma,,0.4,5+4=9,Yes,,,,,,,,,,,,
6,,20210914,,50,90,182,,,1,Prostate,1c,0,0,Very High,Prostate,,,Clinical,Carcinoma,,1.5,5+5=10,No,40,4.0 x 3.8 x 3.9,,,,,,,,,,
7,,11379642,17063,75,121kg,175cm,M,,0,Prostate/Pelvis,4,0,0,Very High,Prostate,0,0,Clinical,Carcinoma,,20,4+4,No,32,4.5 x 3.3 x 4.2,,,Curative ,None,None,None,,,,"Relugolix, Abiraterone 24 mo"
8,,10508813,20536,65,80kg,170cm,M,,0,Prostate/Pelvis,2,0,0,High,Prostate,0,0,Clinical,Carcinoma,,18,4+3,No,40,4.3 x 3.8 x 4.0,,,Curative,None,None,None,,,,Lupron 24 months
9,,15108235,13287,83,63.5,158cm,M,,0,Prostate/Pelvis,1c,0,0,Intermediate,Prostate,0,0,Clinical,Carcinoma,,6,4+3,No,93,6.5 x 4.5 x 6.1,,,Curative,No,No,NO,,,,relugolix 
10,,11068413,16762,75,83,163,M,,1,Pelvis/Prostate Bed,3b,0,0,Very High,Prostate Bed,0,0,Pathological,Carcinoma,,2,4+3,Yes,31,3.8 x 3.6 x 4.3,,,Curative,No,No,Yes,,,,Degarelix